JENNIFER MENDRYSA: Open Payments
NPI 1982076899 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 27 payments from 9 companies in 2025. Trend: 2023 $539 · 2024 $556 · 2025 $930
Food & beverage: $862Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $281 |
| Sumitomo Pharma America, Inc. | 9 | $210 |
| Boston Scientific Corporation | 1 | $164 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $93 |
| Teleflex LLC | 2 | $59 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Antares Pharma, Inc. | 1 | $30 |
| UROGEN PHARMA, INC. | 1 | $25 |
| COLOPLAST CORP | 1 | $17 |
Products named: ERLEADA, GEMTESA, Axonics, ADSTILADRIN, BARRIGEL, XYOSTED, JELMYTO, UROLIFT.
Industry payments across VA — which companies pay providers there.
